| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Liu Chang | 10%+ Owner | C/O CURANEX PHARMACEUTICALS INC, 2 JERICHO PLAZA SUITE 101 B, JERICHO | /s/ Chang Liu | 02 Sep 2025 | 0002084036 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CURX | Common Stock | 4,870,020 | 25 Aug 2025 | Direct | ||||||
| holding | CURX | Common Stock | 2,340,000 | 25 Aug 2025 | See footnote | F1 | |||||
| holding | CURX | Common Stock | 772,200 | 25 Aug 2025 | See footnote | F2 | |||||
| holding | CURX | Series A Preferred Stock | 310,000 | 25 Aug 2025 | Direct |
| Id | Content |
|---|---|
| F1 | These shares of common stock are held directly by Korovyev Hippo LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Korovyev Hippo LLC. |
| F2 | These shares of common stock are held directly by Liu and Company LLC, an entity in which the Reporting Person has the sole voting and investment power. By virtue of this relationship, the Reporting Person may be deemed to have the sole beneficial ownership of the securities held of record by Liu and Company LLC. |